 |
Previous Article | Next Article 
Volume 16, Number 16,
Issue of August 15, 1996
pp. 4949-4957
Copyright ©1996 Society for Neuroscience
Myomodulin Gene of Lymnaea: Structure, Expression,
and Analysis of Neuropeptides
Elaine Kellett,
Stephen J. Perry,
Niovi Santama,
Belinda
M. Worster,
Paul R. Benjamin, and
Julian F. Burke
Sussex Centre for Neuroscience, School of Biological Sciences,
University of Sussex, Falmer, Brighton BN1 9QG, United Kingdom
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
The myomodulin family of neuropeptides is an important group of
neural cotransmitters in molluscs and is known to be present in the
neural network that controls feeding behavior in the snail
Lymnaea. Here we show that a single gene encodes five
structurally similar forms of myomodulin: GLQMLRLamide, QIPMLRLamide,
SMSMLRLamide, SLSMLRLamide, and PMSMLRLamide, the latter being present
in nine copies. Analysis of the organization of the gene indicates that
it is transcribed as a single spliced transcript from an upstream
promoter region that contains multiple cAMP-responsive elements, as
well as putative elements with homology to tissue-specific
promoter-binding sites. The presence in nervous tissue of two of the
peptides, GLQMLRLamide and PMSMLRLamide, is confirmed by mass
spectrometry. In situ hybridization analysis indicates that
the gene is expressed in specific cells in all ganglia of the CNS of
Lymnaea, which will allow physiological analysis of the
function of myomodulins at the level of single identified neurons.
Key words:
myomodulin;
neuropeptide;
gene;
Lymnaea;
molluscs;
neuronal modulation
INTRODUCTION
Studies aimed at understanding the signaling
function of neuropeptides have emphasized the value of using model
invertebrate systems, such as gastropod molluscs, in which the pattern
of gene expression and the physiological function of processed peptides
can be studied at the level of single identified neurons (Cropper et
al., 1987 , 1991 ; Benjamin and Burke, 1994 ). A common feature of
invertebrate neuropeptide genes is that they encode a variety of
structurally related peptides present on one or more precursor
proteins. Families of related peptides occur in the same type of animal
but, in addition, related families can be recognized in other species
as well, resulting in enormous interphyletic diversity of peptide
structures. An important example of this structural diversity is the
myomodulin family of molluscan neuropeptides. Myomodulin A
(PMSMLRLamide) and eight related peptides were first discovered by
molecular and biochemical methods in Aplysia (Cropper et
al., 1987 , 1991 ; Lopez et al., 1993 ; Miller et al., 1993 ; Brezina et
al., 1995 ). Myomodulin A is now known to be present in several other
molluscs together with at least one more related molecule (Fugisawa et
al., 1990 ), and further types of myomodulin are also likely to be
discovered with further investigation.
In the pulmonate snail Lymnaea, the presence of myomodulin A
was confirmed by HPLC purification and sequencing of CNS extracts
(Santama et al., 1994a ) and by mass spectrometry of the penis nerve (Li
et al., 1994 ). Application of myomodulin A to the penis enhanced the
amplitude of electrically induced contractions and increased the
relaxation rate of the penis muscle (van Golen et al., 1996 ). This
indicated that myomodulin plays a role in modulating neuromuscular
transmission. This was also the case in Aplysia, in which an
important physiological study showed that the myomodulin peptides acted
in concert to enhance acetylcholine-induced contractions in a specific
muscle of the buccal mass, the feeding apparatus of molluscs (Brezina
et al., 1994a ,b). The presence of myomodulin-like peptides in the
feeding system of Lymnaea was also indicated by detailed
immunocytochemical studies (Santama et al., 1994b ). As well as feeding
motoneurons, immunoreactivity was also found in identified modulatory
interneurons of the feeding network, suggesting a central function for
myomodulin as well as the peripheral neuromuscular function in feeding,
already shown for Aplysia.
The likely presence of the myomodulins in several behaviorally
important networks in Lymnaea made it important to carry out
a molecular analysis of the Lymnaea gene. The aim was to
discover the full range of myomodulin-like peptides in
Lymnaea and to provide a more specific molecular probe for
in situ hybridization analysis of the CNS. We describe the
structure of cDNAs encoding myomodulin A and four structurally related
peptides, the organization of the gene and its promoter, and its
expression in the CNS (in situ analysis). Preliminary mass
spectrometric evidence confirmed the presence of diverse myomodulins in
nervous tissue.
MATERIALS AND METHODS
Specimens of wild Lymnaea stagnalis, collected from
freshwater ponds, were supplied by Blades Biological (Edenbridge, Kent,
UK). A supply of captive-bred snails was also supplied by the
Department of Biology at the Vrije Universiteit (Amsterdam, The
Netherlands). Both types of snail were maintained at 20°C in 40 l aquaria in drip-fed tap water, kept under a 12 hr light/dark cycle
and fed on washed lettuce ad libitum. All molecular biology
procedures followed the protocols in Sambrook et al. (1989) .
Isolation of cDNA clones. A random-primed
[ -32P]dCTP-radiolabeled cDNA probe encoding
a portion of the Aplysia myomodulin propeptide (Miller et
al., 1993 ) (kindly donated by K. R. Weiss, Mt. Sinai School of
Medicine, New York, NY) was used to screen a Lymnaea CNS
cDNA library constructed in the vector ZAP II (previously described
in Vreugdenhil et al., 1988 ). Hybridization was performed on duplicate
filters of 2 × 104 plaques at 65°C
overnight in a hybridization solution containing 3× SSC, 0.1% (w/v)
SDS, and 5× Denhardt's solution [0.2% (w/v) polyvinylpyrrolidine,
0.2% (w/v) bovine serum albumin, and 0.2% (w/v) Ficoll]. After four
washes at 65°C in 0.2× SSC and 0.1% SDS, the filters were left on
preflashed X-ray film overnight at 70°C. Duplicate positive plaques
were purified through secondary and tertiary screens, and the cDNA
clones were isolated by in vivo excision of the pBluescript
SK plasmid (Stratagene, La Jolla, CA). In this
way, six cDNAs that showed homology to the open reading frame of the
Aplysia sequence were isolated.
Isolation of genomic clones. EcoRI-digested
genomic DNA was used to construct a library in the vector gt10.
Duplicate filters of 5 × 105 plaques were
screened using randomly primed probes of both EcoRI
fragments of the Lymnaea cDNA clone pMM421. Hybridization
was performed in the same manner as described for isolation of the cDNA
clones, but washes were performed at 65°C with 0.1× SSC and 0.1%
SDS. Overnight exposures of the filters revealed four positively
hybridizing plaques. After tertiary screens, purified plaques were
isolated and the inserts were isolated by restriction digestion with
EcoRI and subcloned into pUC19.
Sequencing of clones. Restriction digestion of isolated cDNA
and genomic clones and subsequent subcloning of the fragments into
pUC19 were performed. All subclones were sequenced by the Sanger method
of chain termination from double-stranded DNA using fluorescent
dye-primer cycle sequencing kits (ABD, Warrington, UK) and analyzed on
a 373A automated DNA sequencer (ABD).
5 -Exon extension using PCR. The only region of the cDNA
clones that was not present in the previously isolated fragments of the
gene (see Results) was confirmed as being the 5 end of the second exon
by PCR. A primer designed for the very 5 end of the absent region
(MidS1: AATACAGAAGAATCCGGTGGCCAG) was used in conjunction with three
primers designed for regions of the reverse complement strand both in
the large exon and in the 3 region of the absent fragment (MidA1:
AGCAAGCTCAAAATGTCGTCTATGT; MidA2: GAATTCCGGGTTCTGCTCTT-GGTA; GMM36A2:
ACCTCCTGAACCTGTGGTGTTCAG). Reactions were carried out in 50 µl
volumes using 20 ng of genomic DNA as the template, 50 pmol of each
primer, 200 µM dNTPs (Pharmacia, Uppsala,
Sweden), 5 µl of 10× PCR buffer (500 mM KCl,
20 mM Tris, pH 8.4, and 20 mM MgCl2). Cycling
conditions were as follows: three cycles of 94°C for 2 min, 65°C
for 2 min, followed by 27 cycles of 94°C for 30 sec, 65°C for 30 sec, and 72°C for 1 min. One unit of Amplitaq DNA polymerase (ABD)
was added at the annealing temperature of the first cycle as in a
hotstart protocol. The sizes of the PCR products were determined by
electrophoretic separation on a 1.2% agarose gel and were cloned into
the pCR II cloning vector (R&D Systems), and the sequences of both
strands were determined as described previously for the library
clones.
Transcriptional start-site mapping by primer extension.
Primer MMRTA1, complementary to the coding strand of pGMM28A between
1254 and 1276 bp (ATGTTCTTGACGTATGTTGGCGT), was 5 -radiolabeled with
[ -32P]ATP for use in primer extension after
hybridization to CNS total RNA. Two hundred nanograms of primer were
incubated at 37°C for 1 hr in a 20 µl reaction mix with 2 µl of
10× kinase buffer [700 mM Tris, pH 8.0, 100 mM MgCl2, and 5 mM dithiothreitol (DTT)], 30 µCi of
[ -32P]ATP, and 10 U of T4 polynucleotide
kinase. After precipitation, 0.5 fmol of primer was incubated with 20 µg of CNS total RNA in a volume of 11 µl at 70°C for 10 min,
followed by rapid cooling to 40°C for 10 min to allow primer
annealing. The mixture was placed on ice, and 4 µl of 5×
first-strand synthesis buffer (250 mM Tris-HCl,
pH 8.3, 375 mM KCl, and 15 mM MgCl2), 2 µl of 0.1 M DTT, 1 µl of 10 µM
dNTP stock solution, and 200 U of MMLV reverse transcriptase were added
(Superscript II, Life Technologies). The reaction was incubated for 1 hr at 45°C and stopped by the addition of 4 µl of 0.5 M EDTA. The reverse transcription products were
size-fractionated on a 6.5% polyacrylamide gel, using a cytosine
sequencing reaction of clone pGMM28A from the same primer site as a
molecular weight marker (standard sequencing reaction using the
Sequenase Kit, Amersham Life Sciences). The gel was fixed and dried
before autoradiography for 24 hr.
Southern blot analysis. Genomic DNA Southern blots were
performed to elucidate the size of the intervening sequence in the
coding region of the gene. In each restriction digest, 10 µg of
genomic DNA extracted from the buccal mass, brain, and reproductive
organs of 10 snails was digested overnight at 37°C and
size-fractionated on a 0.6% agarose gel. After depurination,
denaturation, and neutralization, the DNA was transferred onto a nylon
filter (Amersham) and permanently cross-linked by exposure to
ultraviolet light. Hybridization was performed under the same
conditions as described for the screening of the genomic library, using
the randomly primed PCR product pMID2 (Fig. 3b) as a
hybridization probe. The filter was autoradiographed overnight at
80°C with preflashed film and an intensifying screen.
Fig. 3.
The genomic organization of the myomodulin gene.
a, PCR amplification of the 5 end of the second exon using
primers specific for the cDNA sequence (arrows labeled
GMM36A2, midS1, midA1, and
midA2) produced three products
(pMID1, pMID2, and pMID3).
Sequencing of these confirmed that the region of the cDNAs absent from
genomic clones pGMM28A and pGMM36A is uninterrupted
and lies at the 5 end of the second exon. b, Southern blot
analysis of restriction-digested Lymnaea genomic DNA using
the PCR product pMID2 as a hybridization probe. Restriction digests
with EcoRI (lanes 2, 3,
7) produced a single band of 2.7 kb, whereas
restriction digests with PstI (lanes 4,
5) produced a 20 kb band (indicated with arrows).
Because of the high-stringency washing of the filter, the second
PstI restriction fragment was not detected by the probe
because of its short length of overlapping sequence (30 bp).
1, Undigested DNA; 2, EcoRI;
3, EcoRI/PstI; 4,
PstI; 5, PstI/SalI;
6, SalI; 7,
EcoRI/SalI. This photograph has been
electronically enhanced for improved clarity. c, Deduced map
of the myomodulin gene with a single large intron of ~19 kb
(black line). All restriction fragment sizes are given
in kb. The black region indicates the position of the PCR
product pMID2 used as the hybridization in Figure 5B; the
positions of genomic clones pGMM28A and pGMM36A
are indicated by diagonally striped boxes.
[View Larger Version of this Image (37K GIF file)]
Northern blot hybridization. Total RNA was isolated from the
CNS of 50 Lymnaea, and 20 µg was size-fractionated on a
1% agarose gel in 10 mM sodium phosphate running
buffer (method described by Pellé and Murphy, 1993 ). The RNA was
transferred to a nylon membrane and permanently cross-linked to it by
exposure to ultraviolet light. Hybridization with the randomly primed
[ -32P]dCTP-labeled cDNA clone pMM421 was
performed overnight at 68°C with the same buffer used for library
screening. Washes were performed at 68°C with 0.1× SSC and 0.1% SDS
before overnight autoradiography.
In situ hybridization. The entire CNS was isolated, and
nerves and connective tissue sheaths were removed before snap freezing
in liquid freon and immersion in liquid nitrogen. The tissue was
freeze-dried for 24 hr, fixed in paraformaldehyde vapor (60°C, 90 min), and embedded in wax. Sections were cut (7 µm) and arranged on
gelatin/chrome alum-coated slides and dried overnight at 37°C. Before
hybridization, the sections were dewaxed (xylene, 20 min), washed in
methanol (2 min), permeabilized with 0.1% pepsin (10 min), fixed in
2% paraformaldehyde in PBS (4 min), and blocked by 1%
hydroxylammonium chloride (15 min). Hybridization, using an
oligonucleotide complementary to a coding region of the gene (P25:
GAAGCTCGTCCACGTCTCCGTA), 3 -tailed by terminal transferase with
digoxigenin-11-UTP, was carried out overnight in hybridization buffer
(25% deionized formamide, 3× SSC, 500 µg/ml sheared salmon sperm
DNA, 500 µg/ml yeast tRNA, and 1× Denhardt's solution) at 55°C.
Washes were carried out the next day (3× SSC, 20 min, 25°C; 3× SSC,
20 min, 55°C; 3× SSC, 10 min, 25°C) before nonspecific binding
site blocking [1% blocking reagent (Boehringer Mannheim) in 100 mM maleic acid, pH 7.5, 150 mM NaCl, and 100 mM Tris,
pH 7.5, 10 min] and incubation with anti-digoxigenin/alkaline
phosphatase-conjugated Fab fragment (Boehringer Mannheim; 1 hr in
blocking buffer). After washing to remove unbound antibody (twice for 5 min each in 100 mM Tris, pH 7.5, and 150 mM NaCl), the slides were covered with the
substrate mixture (10 mM Tris, pH 9.0, 10 mM MgCl2, 165 µg/ml BCIP,
and 330 µg/ml NBT) and the color reaction was allowed to develop in a
light-proof box until a sufficient level of staining was reached.
Slides were washed (100 mM Tris, pH 7.5, and 150 mM NaCl, 5 min) and overlaid with Immumount
(Shandon) and coverslips.
Mass spectrometric analysis of nervous tissue. Small lengths
of the external right parietal nerve were dissected out and placed on
the mass spectrometer target in 5 µl of 0.5% dihydroxybenzoic acid
(DHB). The tissue was crushed and ripped with fine forceps to release
peptides into the DHB matrix solution. The sample was allowed to dry
and was analyzed on a Micromass Matrix-Assisted Laser Desorption
Ionization Time-of-Flight Mass Spectrometer (MALDI-TofSpec, Micromass
Organic, Wythenshawe, UK). Short laser bursts (3 nsec, 337 nm
wavelength) were used to ionize the peptides, which were focused using
a reflectron system to enhance the resolution of the mass peaks.
RESULTS
Characterization of three classes of cDNA clones encoding a
myomodulin prepropeptide
To isolate a cDNA copy of the myomodulin gene transcript, a
Lymnaea total CNS cDNA library was screened with the
Aplysia myomodulin cDNA clone. Six positively hybridizing
clones were produced, and each was digested with the restriction
enzymes EcoRI or BamHI to release the inserts
from the vector DNA. EcoRI produced two fragments for each
clone, and BamHI produced a single fragment. The
BamHI restriction fragments varied in size for each clone,
suggesting that the clones were not identical (data not shown).
Sequencing of the clones, however, showed that all six originated from
the transcription of a single gene. The observed variation in the
lengths of the clones was shown to be attributable to differential use
of three polyadenylation signals (indicated in Fig.
1a) and varying degrees of 5
end truncation. The sequence of the longest cDNA clone, pMM421, is
shown in Figure 1b, with 32 bp at the 5 end derived from
three shorter cDNAs, which exhibited less 5 end truncation (EMBL
database accession number X96933[GenBank]).
Fig. 1.
Three classes of myomodulin cDNA from
Lymnaea stagnalis. a, Schematic diagram of a
class III myomodulin cDNA, indicating the position of the untranslated
regions (white bars) and the open reading frame
(hatched bar). The position of the EcoRI
restriction site (E) at 826 bp is shown. The three
alternative polyadenylation signals used in the three classes of cDNA
are marked with arrows and the base position in the complete
nucleotide sequence (b). b, The complete
nucleotide sequence of a class III myomodulin cDNA. The deduced
sequence of the precursor protein encoded by the open reading frame
(588-1637 bp) is also given; the amino acid residue positions are
underlined on the right. The stop codon is shown
as an asterisk. The three polyadenylation signals are
bold and underlined, and the polyadenylation
sites are marked by vertical lines. The
arrowhead at 645 bp marks the position at which the intron
lies within the gene. Potential peptides within the opening reading
frame are underlined.
[View Larger Version of this Image (46K GIF file)]
Computer-based analysis of the 5 end of the cDNA sequence revealed a
methionine start codon (AUG) at position 526 followed by a short
(7-amino-acid) open reading frame and a stop codon (UGA). The 526 bp of
sequence upstream of this is punctuated with stop codons, and has a
high (A+T) base content, indicative of noncoding DNA in
Lymnaea. A second start codon at position 588 begins a 350 codon open reading frame, ending at position 1640 with a UGA stop
codon. This is the major open reading frame in all six cDNA clones, and
translation of its sequence is shown in Figure 1b. The
sequence surrounding this start codon (AGACC C) compares
well with the Kozak consensus, whereas the equivalent sequence around
the first start codon at position 526 does not match the consensus
(Kozak, 1987 ). It seems most likely, therefore, that translation
initiation occurs at the second start codon.
The stop codon at position 1640 is followed by a variable length of
untranslated DNA, which contains two perfect polyadenylation signals
(AAUAAA; Proudfoot, 1991 ) at positions 1972 and 2426, whereas clone
pMM421 (the longest, a class III clone in Fig. 1a) ends 18 bp after a possible imperfect polyadenylation signal (AAUAGA) at
position 2747, but lacks a polyA tail. The shortest clones (class I in
Fig. 1a: pMM52, pMM53, and pMM511) all end 16-19 bp after
the first polyadenylation signal; clones pMM52 and pMM53 both end with
polyA tails (60 and 11 nucleotides, respectively), whereas pMM511 lacks
a polyA tail. The class II clones, pMM46 and pMM54, utilize the second
polyA signal at position 2426 and end 14-16 bp 3 to this; both have
10 nucleotide polyA tails. Both the 5 - and the 3 -untranslated regions
(587 and 356-1130 bp, respectively) are unusually long compared with
other molluscan neuropeptide genes, including the equivalent
transcripts isolated from Aplysia (Lopez et al., 1993 ;
Miller et al., 1993 ). Functional significance for the alternate use of
different polyadenylation sites and the extraordinary
length of the untranslated regions has yet to be determined.
Structure of the deduced prepropeptide encoded by the cDNAs
Translation of the open reading frame between 588 and 1640 bp in
Figure 1b would produce a 350 residue polypeptide with a
predicted molecular mass of 40.4 kDa. The full complement of peptides
predicted from the deduced amino acid sequence of the myomodulin cDNA
is given in Figure 2. Analysis of the N-terminal 30 amino acids of the polypeptide shows properties of a signal peptide
with a highly hydrophobic core (residues 4-17), after which the
polypeptide becomes hydrophilic. A cleavage site after
Gly20 is predicted by the 1, 3 rule (von
Heijne, 1986 ) and is indicated by a drop in the hydrophobicity of the
polypeptide beyond this point (Kyte and Doolittle, 1982 ; Hopp, 1986 ).
Cleavage at this point would produce a 330-amino-acid propeptide that
encodes five different myomodulin-like peptide sequences. These are
flanked at the N terminus by lysine-arginine basic amino acid pairs
(sites of endoproteolytic cleavage), with the exception of the first
predicted peptide sequence, GLQMLRLG, which is preceded only by a
single arginine residue; endoproteolytic cleavage at such sites is also
well documented (Newcomb et al., 1987; Linacre et al., 1990 ). All of
the putative peptides are flanked at the C terminus by glycine residues
followed by a pair of basic amino acids. Glycine residues at the
predicted C termini of peptides are enzymatically processed to amide
groups in the mature peptides (Bradbury et al., 1982 ). Each peptide is
expected to be amidated, and one peptide, QIPMLRLamide, may also be
cyclized at the N terminus to give a pyroglutaminyl group
(pQIPMLRLamide). The copy number of the different classes of peptides
varies, with nine tandemly arranged copies of myomodulin A
(PMSMLRLamide: peptide 5 in Fig. 2) situated near the C terminus, two
copies of SLSMLRLamide, and one copy each of the other three peptides
located nearer the N terminus. The C-terminal four amino acids (MLRL)
are conserved in all five peptide structures, as is the glycine
amidation signal. All of the variation in the peptide structures occurs
in the N-terminal three residues. Myomodulin A (PMSMLRLamide) and
SMSMLRLamide only vary by a single amino acid at position 1 (Pro Ser); SLSMLRLamide is structurally identical to these but has an
additional conservative substitution at position 2 (Met Leu).
Position 2 is occupied by an apolar residue in all five peptides (Leu,
Met, and Ile), and most variation occurs at positions 1 and 3, where
charged, polar, and apolar residues are found.
Fig. 2.
The organization of the myomodulin prepropeptide.
The putative peptide coding regions are shown in white and
are numbered. The hydrophobic leader sequence is labeled
S, and the spacer regions are stippled
bars. The predicted leader sequence cleavage site at residue
Gly20 is marked with an arrow. All
putative endopeptidase cleavage sites are shown as black
lines, and the sequence of the sites is given above
each line. The amino acid sequence of the peptides is given with
the number of copies of each encoded within the precursor given in
parentheses.
[View Larger Version of this Image (29K GIF file)]
Of the 350 amino acids within the prepropeptide, 183 (52%) are
not within the myomodulin-like peptides, their presumed processing
sites or the signal peptide, but are found in five highly negatively
charged spacer regions (33% of the residues are Asp or Glu) between
the peptide-encoding regions. The most C-terminal of the spacers
(residues 339-350) contains a dibasic endopeptidase cleavage site
which, if cleaved, would release two pentamers: one highly negatively
charged, EDDEE, and the other with the sequence SLAMS. Neither of these
peptides shows homology to any known neuropeptide. The two largest
spacers (residues 21-53 and 65-178) are bisected by furin-like
endopeptidase cleavage sites [RX(K/R)R- residues 41-44 and 114-117]
that may act as sites of primary endoproteolytic cleavage within the
trans-Golgi (Hosaka et al., 1991 ).
Genomic organization of the myomodulin gene
Four hundred thousand plaques of a genomic library constructed
from EcoRI-digested Lymnaea genomic DNA were
screened using EcoRI fragments of the class III cDNA clone
pMM421. Two positively hybridizing plaques were isolated, and
restriction digestion with EcoRI revealed that they had
insert sizes of ~3.6 and ~2.8 kb (pGMM36A and pGMM28A,
respectively). Alignment of the sequence of clone pGMM36A with that of
the cDNAs showed that it began at the EcoRI site at 861 bp
of the cDNA clones (see Fig. 1b) and represented the entire
uninterrupted sequence of cDNA clone pMM421 3 to this restriction site
(1909 bp) and another 1435 bp of novel sequence past its end. Within
this novel region are located a putative downstream RNA 3 cleavage
signal (CATGTTTC; Birnstiel et al., 1985 ) and A/T- and G/T-rich tracts
that may act as transcriptional termination signals (Birnstiel et al.,
1985 ; Guntaka, 1993 ).
Clone pGMM28A (EMBL database accession number X96934[GenBank]) contained
uninterrupted sequence identical to bases 1-645 of the cDNA sequence
in Figure 1b, after which point the sequence diverged at the
sequence TAGGTGAGT, which follows the consensus for the mammalian 5
donor splice site almost exactly (MAG|GTRAGT; Jacob and Gallinar,
1989 ). Analysis of the sequence 3 to this putative splice site did not
reveal a 3 acceptor splice site, a branch sequence, or an open reading
frame, indicating that all of the sequence beyond the 5 splice site
represents part of an intron within the coding region of the gene. The
5 splice junction falls within the codon for
Gly20 of the major open reading frame, the last
codon of the signal peptide. Therefore, the first exon of the
myomodulin gene contains the 5 -untranslated region and the first 20 codons of the precursor protein. The significance of the positioning of
this intron with respect to possible alternate splice forms of the gene
is discussed later.
The two genomic DNA fragments isolated included 2556 bp of the 2770 bp
of cDNA sequence given in Figure 1b. The 214 bp of sequence
not included in these clones were shown to lie at the 5 end of the
sequence included in genomic clone pGMM36A by PCR amplification of this
region from genomic DNA. Primer pairs designed against the cDNA
sequence across this region (as described in Materials and Methods and
represented by arrows in Fig. 3a)
produced three PCR products that were isolated, cloned, and sequenced.
In this way, the entire coding region and the 5 - and 3 -untranslated
regions were shown to lie in two exons separated by an intron of
unknown length. The length of this intron was revealed by hybridization
of clone pMID2 (the PCR product generated using primers midS1 and
midA1) to genomic DNA digested with the restriction enzymes
EcoRI, PstI, and SalI, and in
combinations of pairs of these enzymes followed by size fractionation
by gel electrophoresis (Fig. 3b). A single hybridizing band
was detected in all lanes except the SalI-digested DNA, in
which two bands of 25 and >30 kb were observed. All digests with
EcoRI, whether singularly or in combination with other
enzymes, produced a band of 2.7 kb, whereas the PstI and
PstI/SalI digest produced a single band of 20 kb.
These data, in combination with the restriction maps of the two genomic
clones previously isolated, predict an intron length of ~19 kb, in
which there are no PstI or SalI sites, but two
EcoRI sites 836 bp 3 to the 5 donor splice site, and
~2.5 kb 5 to the 3 acceptor splice site (Fig. 3c).
Mapping of the transcriptional start site
To confirm that the cDNA clones isolated represented
almost complete transcript copies, the transcriptional start site of
the myomodulin gene was identified by primer extension mapping. Twenty
micrograms of CNS total RNA were reverse-transcribed from the primer
MMRTA1 and size-fractionated by PAGE. The C reaction of a sequencing
reaction of clone pGMM28A from the same primer site was used as a size
marker (Fig. 4a). Two high-intensity
reverse-transcribed products and a weaker band were observed,
corresponding closely to the region in which some of the cDNA clones
have their start points. The positions of transcription initiation
within the CNS, therefore, are very close to the 5 ends of some of the
cDNAs. Therefore, all of the sequence of the genomic clone pGMM28A 5
to these sites corresponds to the promoter and upstream control regions
of the myomodulin gene.
Fig. 4.
a, Transcriptional start site mapping
of the myomodulin gene. Three products of reverse transcription of
total CNS RNA from the radiolabeled primer MMRTA1 were separated by
PAGE (lane i) using the ddCTP reaction of a manual
sequencing reaction as a size marker (lane C). The
sequence of genomic clone pGMM28A to which the marker corresponds is
shown on the right (cytosines are underlined).
The nearest adenosines to which the reverse transcription products
could correspond are marked with arrows (the faint largest
product is marked by a gray arrow). The first base of the
least truncated cDNA clone isolated is marked with an
asterisk. b, Northern blot of total CNS RNA
hybridized with a radiolabeled class III myomodulin cDNA. Six bands of
3.8, 3.2, 2.8, 2.6, 2.1, and 1.5 kb (indicated with arrows)
were detected. Three of these correspond to sizes predicted for the
three classes of myomodulin cDNA isolated (2.1, 2.6, and 2.8 kb).
[View Larger Version of this Image (45K GIF file)]
Structure of the myomodulin gene promoter
Genomic clone pGMM28A contains up to 1104 bp of DNA positioned 5
to the point of transcriptional initiation. This is likely to form part
or all of the promoter region of the gene. Possible control elements
within this region were identified by comparison of its sequence with
the Eukaryote Promoter Database (EPD), available as part of the EMBL
DNA sequence database, manual searches for the sequences of known
control elements (Locker and Buzzard, 1990 ), and direct sequence
comparisons to three published Aplysia neuropeptide gene
promoter sequences (DesGroseillers et al., 1987 ). These searches
revealed a number of putative sequence elements that may be involved in
the control of transcription initiation (Fig. 5),
including an imperfect TATA box sequence (GATAAA) at 28, and
cAMP-responsive elements (CRE and AP-2) at 133, 445, 839, and
1021. Two AP-5 elements, also present in the Aplysia L11
neuropeptide gene promoter (at 54 and 285), are present as well as
a number of sequences with homology to tissue-specific elements
(liver-specific promoter element LF-A1 at 442 and 687;
immunoglobulin promoter elements µE1 at 204; and µE4 at 297).
Thus, the promoter region appears to contain a number of different
types of control elements that may allow the rate of transcription
initiation to be controlled in response to a variety of cellular
factors. This would be expected of a gene that encodes peptides
expressed in several behaviorally important neural systems.
Fig. 5.
Analysis of potential promoter elements in the
myomodulin gene promoter. Genomic clone pGMM28A is an EcoRI
restriction fragment (E) consisting of 1100 bp of DNA 5 to
the transcriptional start sites (white bar and
horizontal arrow labeled +1), a 645 bp exon
(Exon I: shaded bar) and 842 bp of intron
(line). The sequence of the 5 splice junction is shown. The
promoter region is expanded to show the predicted promoter elements and
their positions with respect to the transcriptional start point (see
Results).
[View Larger Version of this Image (16K GIF file)]
Expression of the myomodulin gene in the CNS
The presence of the myomodulin transcripts within the CNS of
Lymnaea was confirmed by hybridization of the cDNA clone
pMM421 to size-fractionated total CNS RNA (Fig. 4b). After a
12 hr exposure of X-ray film, four strongly hybridizing bands of 2.6, 2.8, 3.2, and 3.8 kb were visible. The two smaller bands appeared as a
single intense band, but shorter exposures and densitometer readings
allowed them to be distinguished. After longer exposures (36-72 hr),
two additional bands of 2.1 and 1.5 kb were also observed. The 2.1, 2.6, and 2.8 kb species of transcript detected correspond well with the
mRNA lengths expected for the three classes of myomodulin cDNA isolated
from the cDNA library. The 3.2, 3.8, and 1.5 kb transcripts may
represent other mRNA species transcribed either from the gene described
here, utilizing cryptic promoter or polyadenylation signals, or from a
second gene with high sequence homology. The latter explanation seems
unlikely in view of the Southern hybridization data. The relative
amounts of the different transcripts can also be estimated from the
intensity of the bands, which suggests that the class II and III
transcripts are of approximately the same abundance in the CNS, whereas
the shorter class I transcripts are 10-fold less abundant.
Myomodulin gene transcripts were also directly detected in
Lymnaea nervous tissue by in situ hybridization
of an antisense digoxigenin-labeled 25 nucleotide oligomer to fixed 7 µm sections of the CNS. Transcripts were detected in the cytoplasm of
~1000 neurons located in all ganglia of the brain, suggesting that
the gene is widely and abundantly expressed (Fig. 6).
Variation in transcript concentration within neurons was indicated by
differences in the intensity of staining observed. Complementary strand
probes and RNase-treated sections both failed to show any staining,
indicating that the observed hybridization with the antisense probe was
specific for myomodulin gene transcripts (data not shown).
Fig. 6.
Localization of myomodulin transcripts to neurons
in the CNS of Lymnaea. In situ hybridization with a 25 mer
oligonucleotide complementary to part of the myomodulin cDNA sequence
revealed the presence of transcripts in the cytoplasm of a subset of
neurons in all of the ring ganglia and the buccal ganglia.
a, Neurons in the left and right parietal ganglia
(LPG and RPG, respectively) and the visceral
ganglia (VG) exhibit intense staining. b, Neurons
in both the left and the right pedal ganglia (PEG) show a
range of staining intensities, indicating different levels of
expression in neighboring cells. Scale bar, 100 µm.
[View Larger Version of this Image (146K GIF file)]
Detection of myomodulin peptides in nervous tissue
Mass spectrometric analysis of a small piece of the external right
parietal nerve (Fig. 7) revealed the presence of a
number of peptides, including two with masses identical to some of the
predicted myomodulin peptides: 829.8 (GLQMLRLamide) and 846.7 (PMSMLRLamide). The detection of the peptide GLQMLRLamide confirms that
the single basic amino acid at its N terminus, predicted from the cDNA
sequence, is used as an endoproteolytic cleavage site. The three other
myomodulin-like peptides encoded within the gene were not detected
(SMSMLRLamide, SLSMLRLamide, and QIPMLRLamide), but the ionization
capabilities of these peptides may be lower than those of the other
peptides, rendering them undetectable at low concentrations. Control
experiments carried out in this laboratory have shown that the
myomodulin peptides vary in their detectability by MALDI-MS, which are
affected by a number of factors including the concentration of other
peptides within the mixture (data not shown). However, these
experiments showed that all of the different members of the
Lymnaea myomodulin family are capable of detection by
MALDI-MS, and the lack of detection of some of them in the present
tissue probably reflects their low concentration.
Fig. 7.
MALDI-MS analysis of a section of the external
right parietal nerve reveals the presence of two of the myomodulin
peptides predicted from the cDNA sequence. Mass peaks corresponding to
PMSMLRLamide (846.7 Da) and GLQMLRLamide (829.8 Da) are labeled.
[View Larger Version of this Image (30K GIF file)]
DISCUSSION
The results presented here describe the isolation of cDNA and
genomic DNA clones encoding the myomodulin family of neuropeptides in
Lymnaea. Expression of the gene in the nervous system is
confirmed by RNA blot analysis, transcriptional start site mapping, and
in situ hybridization. Translation of transcripts and
processing of the propeptide are also confirmed by detection of some of
the predicted myomodulin peptides within nervous tissue.
Myomodulin gene organization
The myomodulin gene contains a single intron of ~19 kb that lies
within the 20th codon of the major open reading frame. An intron of
unknown size has also been detected in the same position of the
Aplysia myomodulin gene (Miller et al., 1993 ). The
positioning of the intron suggests that it may play a role in the
control of gene expression because failure to remove the intron from
transcripts would disrupt the open reading frame and prevent synthesis
of the myomodulin prepropeptide. The 20th codon of the open reading
frame is predicted to encode the last amino acid of the hydrophobic
leader sequence of the peptide precursor. It is possible, therefore,
that there is alternative splicing between the first exon and
alternative downstream exons similar to the mechanism that is known to
exist for the FMRFamide neuropeptide gene in Lymnaea
(Saunders et al., 1991 , 1992 ). The large size of the intron
theoretically could accommodate other exons; however, no alternatively
spliced exons or cDNAs have been characterized for the myomodulin gene
despite extensive efforts to identify them (our unpublished
observations).
Transcriptional control of the myomodulin gene
Isolation of the promoter region of the gene has revealed several
promoter elements that may play roles in the control of transcription
of the gene. A putative TATA sequence 28 bp upstream of the
transcriptional start site has been identified, but other common
transcription promoter elements, CAAT box and SP-1, for example, are
absent. The in situ hybridization data revealed a
cell-specific pattern of gene expression that discriminated between
neighboring cells within the same ganglia in the brain. Production of
such a specific pattern of transcription would require the absence of
these nonspecific transcriptional inducers and the presence of
cell-specific DNA binding factors and the sequence elements that they
occupy. Such sequence elements have been identified in the myomodulin
gene promoter (Fig. 5), supporting the suggestion of an array of
cell-specific transcription factors controlling the expression of the
gene.
Two types of cAMP-responsive element have been identified: CRE and
AP-2. Both of these elements can act as basal enhancers and as
rapid-response cAMP-dependent enhancers (Imagawa et al., 1987 ; Quinn et
al., 1988 ; Roesler et al., 1988 ). These elements may influence the
level of myomodulin gene expression within neurons by increasing the
rate of transcription when cAMP levels rise. Such increases could be
produced by activation of adenylate cyclases by neurotransmitters
binding to G-protein-coupled receptors on the surface of the cell.
Therefore, the rate of transcription could be influenced by the level
of agonist stimulation of the cell. Vertebrate neuropeptide and
neurohormone gene promoters contain these sequence elements
(somatostatin: Montminy et al., 1986 ; VIP: Tsukada et al., 1987 ;
proenkephalin: Comb et al., 1986 ), suggesting a role for cAMP in the
control of gene expression for a wide range of neural signaling
pathways.
Transcript and prepropeptide structure
Three different classes of myomodulin cDNA were isolated, each
characterized by the position of the polyadenylation signal used for
correct 3 end processing. Although the use of alternative
polyadenylation signals does not alter the structure of the
prepropeptide encoded by the transcripts, it may have significant
effects on the stability of the mRNA and its ability to be translated.
Sequence elements that affect both of these properties of transcripts
have been reported to exist in the 3 -untranslated regions of other
gene transcripts (for review, see Klausner and Harford, 1989 ; Jackson
and Standart, 1990 ). The different quantities of the three classes of
transcript detected by Northern hybridization could be accounted for by
these factors, or simply by a bias in the use of the sites.
The predicted structure of the prepropeptide encodes a 350-amino-acid
polypeptide encoding 14 putative myomodulin-like peptides of five
different structures. Each peptide is flanked by endoprotease cleavage
sites and has a glycine residue at its C terminus, suggesting that the
peptides are all amidated after cleavage from the propeptide. The
detection of two of these peptides by mass spectrometry confirms that
both cleavage and amidation of the peptides do occur. Interestingly,
detection of the peptide GLQMLRLamide also confirms that the single
basic amino acid positioned at its N terminus within the propeptide
does act as a functional endoproteolytic cleavage site. This peptide is
not found in the Aplysia precursor cDNA, but it has been
biochemically isolated from the ARC muscle (Brezina et al., 1995 ).
Failure to detect the other three myomodulin-like peptides predicted
from the propeptide structure (SLSMLRLamide, SMSMLRLamide, and
QIPMLRLamide) may imply that these peptides are not processed from the
polypeptide. This seems unlikely because all three peptides are flanked
by endoproteolytic cleavage sites. The quantities of the detected
peptides were very low (<10 fmol), and the quantities of the other
three peptides may have been too low even for detection by the
sensitive technique of MALDI-MS. The ability of a peptide to be ionized
by laser desorption mass spectrometry is dependent on its structure.
Even structurally similar peptides can have very different ionization
capabilities; therefore, the three peptides not detected may be less
easily ionized than the other two myomodulins. It is likely that all
five peptide types are cleaved from the propeptide and, further,
biochemical and mass spectrometric analysis of nervous tissue would
probably detect all five myomodulins.
Two putative furin endoprotease cleavage sites (residues 41-44 and
114-117) within the propeptide may act as sites of primary processing
in the trans-Golgi network. The most likely cleavage site,
RFRR (residues 114-117), is found within the spacer sequence between
the first two myomodulins, GLQMLRLamide and QIPMLRLamide. This putative
cleavage site is similar to the tetrabasic cleavage sequence
observed in both the Lymnaea FMRFamide (Linacre et al.,
1990 ) and the Aplysia ELH precursor proteins, where it has
been demonstrated to be the first site of processing, allowing the
differential sorting and trafficking of peptides encoded at opposite
ends of the same precursor protein (Sossin et al., 1990 ). A possible
cleavage site is also present at an equivalent position in the
Aplysia myomodulin precursor (Lopez et al., 1993 ; Miller et
al., 1993 ).
This study has revealed the presence of the myomodulin-like peptides in
the nervous system of Lymnaea. The elucidation of the cDNA
sequences and genomic organization has revealed some similarities to
the myomodulin gene of Aplysia (for example, three of the
putative peptide sequences are identical), but there are also several
novel features of this gene and the polyprotein it encodes. The gene
has a promoter containing sequence elements that may confer tissue
specificity and cAMP induction of expression. Alternative use of
polyadenylation sites during post-transcriptional processing of the
transcript occurs, with three different lengths of 3 -untranslated
region existing in detectable quantities within the nervous system.
Three novel peptide structures are described here, and evidence for the
translation and post-translational processing of the polyprotein is
presented.
The myomodulins are an important class of neuropeptides within the
nervous system of Lymnaea and, coupled with the detection of
myomodulin immunoreactivity in several identified neurons involved in
well studied behavioral networks (Santama et al., 1994b ), these
peptides will allow the characterization of a central role for a family
of neuropeptides in the mediation of behavior.
FOOTNOTES
Received March 22, 1996; revised May 22, 1996; accepted May 24, 1996.
This work was supported by a grant from the Biotechnology and
Biological Sciences Research Council. B.M.W. was partly funded by a
CASE award from Micromass UK, Ltd. (Wythenshawe, UK). We thank K. Weiss
and M. Miller for generously supplying the Aplysia
myomodulin cDNA clone used in this work.
Correspondence and reprint requests should be addressed to Stephen J. Perry, Sussex Centre for Neuroscience, School of Biological Sciences,
University of Sussex, Falmer, Brighton, East Sussex BN1 9QG, UK.
Dr. Kellett's present address: Davidson Building, Division of
Biochemistry and Molecular Biology, IBLS, University of Glasgow,
Glasgow, UK.
Dr. Santama's present address: European Molecular Biology Laboratory,
Heidelberg, Germany.
REFERENCES
-
Benjamin PR,
Burke JF
(1994)
Alternative mRNA
splicing of the FMRFamide gene and its role in neuropeptidergic
signalling in a defined neural network.
Bioessays
16:335-342 .
[ISI][Medline]
-
Birnstiel ML,
Busslinger M,
Strub K
(1985)
Transcription
termination and 3
processing: the end is in site!
Cell
41:349-359 .
[ISI][Medline]
-
Bradbury AF,
Finnie MDA,
Smyth DG
(1982)
Mechanism of
C-terminal amide formation by pituitary enzymes.
Nature
298:686-688 .
[Medline]
-
Brezina V,
Evans CG,
Weiss KR
(1994a)
Enhancement of Ca
current in the accessory radula closer muscle of Aplysia
californica by neuromodulators that potentiate its contractions.
J Neurosci
14:4393-4411 .
[Abstract]
-
Brezina V,
Evans CG,
Weiss KR
(1994b)
Activation of K current
in the accessory radula closer muscle of Aplysia californica
by neuromodulators that depress its contractions.
J Neurosci
14:4412-4432 .
[Abstract]
-
Brezina V,
Bank B,
Cropper EC,
Rosen S,
Vilim FS,
Kupfermann I,
Weiss KR
(1995)
Nine members of the myomodulin family of peptide
cotransmitters at the B16-ARC neuromuscular junction of
Aplysia.
J Neurophys
74:54-72 .
[Abstract/Free Full Text]
-
Comb M,
Birnberg NC,
Seasholtz A,
Herbert E,
Goodman HM
(1986)
A cyclic AMP- and phorbol ester-inducible DNA
element.
Nature
323:353-356 .
[Medline]
-
Cropper EC,
Tenenbaum R,
Kolks MAG,
Kupfermann I,
Weiss KR
(1987)
Myomodulin: a bioactive neuropeptide present in an
identified cholinergic buccal motor neuron of Aplysia.
Proc Natl Acad Sci USA
84:5483-5486 .
[Abstract/Free Full Text]
-
Cropper EC,
Vilim FS,
Alevizos A,
Tenenbaum R,
Kolks MAG,
Rosen S,
Kupfermann I,
Weiss KR
(1991)
Structure, bioactivity and
cellular localization of myomodulin B: a novel Aplysia
peptide.
Peptides
12:683-690 .
[ISI][Medline]
-
DesGroseillers L,
Cowan D,
Miles M,
Sweet A,
Scheller RH
(1987)
Aplysia californica neurons
express microinjected neuropeptide genes.
Mol Cell Biol
7:2762-2771 .
[Abstract/Free Full Text]
-
Fugisawa Y,
Kubota I,
Kanda T,
Kuroki Y,
Muneoka Y
(1990)
Neuropeptides isolated from Mytilus
edulis (bivalvia) and Fusinus ferrugineous
(prosobranchia).
In: Comparative pharmacology of neuropeptides
(Stefano, GB,
Florey, E,
eds)
. Manchester: Manchester UP.
-
Guntaka RV
(1993)
Transcription termination and
polyadenylation in retroviruses.
Microbiol Rev
57:511-521 .
[Abstract/Free Full Text]
-
Hopp TP
(1986)
Protein surface analysis: methods for
identifying antigenic determinants and other interaction sites.
J Immunol Methods
88:1-18 .
[ISI][Medline]
-
Hosaka M,
Nagahama M,
Kim WS,
Watanabe T,
Hatsuzawa K,
Ikemizu J,
Murakami K,
Nakayama K
(1991)
Arg-X-Lys/Arg-Arg motif as a
signal for precursor cleavage catalysed by furin within the
constitutive secretory pathway.
J Biol Chem
266:12127-12130 .
[Abstract/Free Full Text]
-
Imagawa M,
Chui R,
Karin M
(1987)
Transcription factor AP-2
mediates induction by two different signal-transduction pathways:
protein kinase C and cAMP.
Cell
51:251-260 .
[ISI][Medline]
-
Jacob M,
Gallinar H
(1989)
The 5
splice site: phylogenetic
evolution and variable geometry of association with U1RNA.
Nucleic Acids Res
17:2159-2180 .
[Abstract/Free Full Text]
-
Jackson RJ,
Standart N
(1990)
Do the polyA tail and 3
untranslated region control messenger-RNA translation.
Cell
62:15-24 .
[ISI][Medline]
-
Klausner RD,
Harford JB
(1989)
Cis-trans models for
post-transcriptional gene-regulation.
Science
246:870-872 .
[Free Full Text]
-
Kozak M
(1987)
An analysis of 5
-noncoding sequences from 699 vertebrate messenger-RNAs.
Nucleic Acids Res
15:8125-8148 .
[Abstract/Free Full Text]
-
Kyte J,
Doolittle RF
(1982)
A simple method for displaying
the hydropathic character of a protein.
J Mol Biol
157:105-132 .
[ISI][Medline]
-
Li KW,
van Golen FA,
van Minnen J,
van Veelen PA,
van der Greef J,
Geraerts WPM
(1994)
Structural identification, neuronal
synthesis, and role in male copulation of myomodulin-A of
Lymnaea: a study involving direct peptide profiling of
nervous tissue by mass spectrometry.
Mol Brain Res
25:355-358 .
[Medline]
-
Linacre A,
Kellett E,
Saunders S,
Bright K,
Benjamin PR,
Burke JF
(1990)
Cardioactive neuropeptide
Phe-Met-Arg-Phe-NH2 (FMRFamide) and novel related peptides
are encoded in multiple copies by a single gene in the snail
Lymnaea stagnalis.
J Neurosci
10:412-419 .
[Abstract]
-
Locker J,
Buzzard G
(1990)
A dictionary of transcription
control sequences: DNA sequence.
J DNA Sequencing Mapp
1:3-11.
-
Lopez V,
Wickham L,
DesGroseillers L
(1993)
Molecular cloning
of myomodulin cDNA, a neuropeptide precursor gene expressed in neuron
L10 of Aplysia californica.
DNA Cell Biol
12:53-61 .
[ISI][Medline]
-
Miller MW,
Beushausen S,
Vitek A,
Stamm S,
Kupfermann I,
Brosius J,
Weiss KR
(1993)
The myomodulin-related neuropeptides:
characterization of a gene encoding a family of peptide cotransmitters
in Aplysia.
J Neurosci
13:3358-3367 .
[Abstract]
-
Montminy MR,
Sevarino KA,
Wagner JA,
Mandel G,
Goodman RH
(1986)
Identification of a cyclic-AMP-responsive element
within the rat somatostatin gene.
Proc Natl Acad Sci USA
83:6682-6686 .
[Abstract/Free Full Text]
-
Newcomb R,
Fisher JM,
Scheller RH
(1988)
Processing of the
egg-laying hormone (ELH) precursor in the bag cell neurons of
Aplysia.
J Biol Chem
263:12514-12521 .
[Abstract/Free Full Text]
-
Pellé R,
Murphy NB
(1993)
Northern hybridization: rapid
and simple electrophoretic conditions.
Nucleic Acids Res
2:2783-2784.
-
Proudfoot N
(1991)
Poly(A) signals.
Cell
64:671-674 .
[ISI][Medline]
-
Quinn PG,
Wong TW,
Magnuson MA,
Shabb JB,
Granner DK
(1988)
Identification of basal and cyclic AMP regulatory
elements in the promoter of the phosphoenolpyruvate carboxykinase gene.
Mol Cell Biol
8:3467-3475 .
[Abstract/Free Full Text]
-
Roesler WJ,
Vandenbark GR,
Hanson RW
(1988)
Cyclic AMP and
the induction of eukaryotic gene transcription.
J Biol Chem
263:9063-9066 .
[Free Full Text]
-
Sambrook J,
Fritsch EF,
Maniatis T
(1989)
Molecular cloning:
a laboratory manual.
.
-
Santama N,
Wheeler CH,
Burke JF,
Benjamin PR
(1994a)
Neuropeptides myomodulin, small cardioactive
peptide, and buccalin in the central nervous system of Lymnaea
stagnalis: purification, immunoreactivity and artifacts.
J Comp Neurol
342:335-351 .
[ISI][Medline]
-
Santama N,
Brierley M,
Burke JF,
Benjamin PR
(1994b)
Neural
network controlling feeding in Lymnaea stagnalis:
immunocytochemical localization of myomodulin, small cardioactive
peptide, buccalin, and FMRFamide-related peptides.
J Comp Neurol
342:352-365 .
[ISI][Medline]
-
Saunders SE,
Bright K,
Kellett E,
Benjamin PR,
Burke JF
(1991)
Neuropeptides Gly-Asp-Pro-Phe-Leu-Arg-Phe-amide
(GDPFLRFamide) and Ser-Asp-Pro-Phe-Leu-Arg-Phe-amide (SDPFLRFamide) are
encoded by an exon 3
to Phe-Met-Arg-Phe-amide (FMRFamide) in the snail
Lymnaea stagnalis.
J Neurosci
11:740-745 .
[Abstract]
-
Saunders SE,
Kellett E,
Bright K,
Benjamin PR,
Burke JF
(1992)
Cell specific alternative RNA splicing of a
FMRFamide gene transcript in the brain.
J Neurosci
12:1033-1039 .
[Abstract]
-
Sossin WS,
Sweet-Cordero A,
Scheller RH
(1990)
Dale's
hypothesis revisited: different neuropeptides derived from a common
prohormone are targeted to different processes.
Proc Natl Acad Sci USA
87:4845-4848 .
[Abstract/Free Full Text]
-
Tsukada T,
Fink JS,
Mandel G,
Goodman RH
(1987)
Identification of a region in the human vasoactive
intestinal polypeptide gene responsible for regulation by cyclic-AMP.
J Biol Chem
262:8743-8747 .
[Abstract/Free Full Text]
-
van Golen FA,
Li KW,
Chen S,
Jimenez CR,
Geraerts WPM
(1996)
Various isoforms of myomodulin identified from the
male copulatory organ of Lymnaea show overlapping yet
distinct modulatory effects on the penis muscle.
J Neurochem
66:321-329 .
[ISI][Medline]
-
von Heijne G
(1986)
A new method for predicting signal
sequence cleavage sites.
Nucleic Acids Res
14:4683-4690 .
[Abstract/Free Full Text]
-
Vreugdenhil E,
Jackson JF,
Bouwmeester T,
Smit AB,
van Minnen J,
van
Heerikhuizen H,
Klootwijk J,
Joosse J
(1988)
Isolation,
characterization, and evolutionary aspects of a cDNA clone encoding
multiple neuropeptides involved in the stereotyped egg-laying behaviour
of the fresh-water snail Lymnaea stagnalis.
J Neurosci
8:4184-4191 .
[Abstract]
This article has been cited by other articles:

|
 |

|
 |
 
M. Michel, I. Kemenes, U. Muller, and G. Kemenes
Different phases of long-term memory require distinct temporal patterns of PKA activity after single-trial classical conditioning
Learn. Mem.,
August 26, 2008;
15(9):
694 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Perry, V. A. Straub, M. G. Schofield, J. F. Burke, and P. R. Benjamin
Neuronal Expression of an FMRFamide-Gated Na+ Channel and Its Modulation by Acid pH
J. Neurosci.,
August 1, 2001;
21(15):
5559 - 5567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Koert, G. E. Spencer, J. van Minnen, K. W. Li, W. P. M. Geraerts, N. I. Syed, A. B. Smit, and R. E. van Kesteren
Functional Implications of Neurotransmitter Expression during Axonal Regeneration: Serotonin, But Not Peptides, Auto-Regulate Axon Growth of an Identified Central Neuron
J. Neurosci.,
August 1, 2001;
21(15):
5597 - 5606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S. Vilim, E. C. Cropper, D. A. Price, I. Kupfermann, and K. R. Weiss
Peptide Cotransmitter Release from Motorneuron B16 in Aplysia californica: Costorage, Corelease, and Functional Implications
J. Neurosci.,
March 1, 2000;
20(5):
2036 - 2042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Hewes, E. C Snowdeal III, M. Saitoe, and P. H. Taghert
Functional Redundancy of FMRFamide-Related Peptides at the Drosophila Larval Neuromuscular Junction
J. Neurosci.,
September 15, 1998;
18(18):
7138 - 7151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Perry, V. A. Straub, G. Kemenes, N. Santama, B. M. Worster, J. F. Burke, and P. R. Benjamin
Neural Modulation of Gut Motility by Myomodulin Peptides and Acetylcholine in the Snail Lymnaea
J Neurophysiol,
May 1, 1998;
79(5):
2460 - 2474.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|